GETI-B:STO
Getinge publ AB
SEKÂ 204,30
arrow_downward
-1,21%(-2,50) 1 HR
15 Jul, 12.22.53 GMT+2 · SEK
search
Semua simbol
1 HR
5 HR
1BLN
6BLN
YTD
1THN
5THN
MAKS
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk GETI-B...
Buka
SEKÂ 207,30
Tinggi
SEKÂ 207,40
Rendah
SEKÂ 204,00
Kapitalisasi pasar
51,92Â M
Volume rata-rata
489,84Â rb
Volume
29,83Â rb
Dividen
2,33%
Dividen per kuartal
SEKÂ 1,19
Tanggal tanpa dividen
22 Apr 2026
Rasio P/E
23,59
Harga tinggi dalam 52 minggu terakhir
SEKÂ 231,60
Harga rendah dalam 52 minggu terakhir
SEKÂ 175,90
EPS
SEKÂ 8,66
Saham beredar
254,15Â jt
Jumlah karyawan
12Â rb
Buka
SEKÂ 207,30
Tinggi
SEKÂ 207,40
Rendah
SEKÂ 204,00
Kapitalisasi pasar
51,92Â M
Volume rata-rata
489,84Â rb
Volume
29,83Â rb
Dividen
2,33%
Dividen per kuartal
SEKÂ 1,19
Tanggal tanpa dividen
22 Apr 2026
Rasio P/E
23,59
Harga tinggi dalam 52 minggu terakhir
SEKÂ 231,60
Harga rendah dalam 52 minggu terakhir
SEKÂ 175,90
EPS
SEKÂ 8,66
Saham beredar
254,15Â jt
Jumlah karyawan
12Â rb
Artikel berita
Dari berbagai sumber di seluruh web
Ad-hoc-news.de
·
9 jam yang lalu
Getinge B stock reflects the Swedish medtech group’s global hospital exposure
Profil
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Tentang Getinge publ AB
Konten AI mungkin berisi kesalahan. Pelajari lebih lanjut